trial

Attachment-focused iMAgery Therapy for PSychosis (A-iMAPS)

NCTId NCT05042050
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 12 (actual)
Sponsored by University of Manchester
Primary completion 2022-11-16
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2022-04-27
Primary completion
2022-11-16
Eligibility
ALL · 16 Years

Interventions & indications

Drugs
A-iMAPS

Sponsors

University of ManchesterLead Sponsor
Pennine Care NHS Foundation TrustCollaborator
Greater Manchester Mental Health NHS Foundation TrustCollaborator

Investigators

1
Katherine Berry, PhDPrincipal Investigator

Sites

1 total
Manchester, United Kingdom

Facts & assertions

4 sourced
Enrollment
12
Phase
NA
Primary Completion Date
2022-11-16
Status
COMPLETED
relationships
The graph out of here
drug
A-iMAPS
drug
lead_sponsor
University of Manchester
company
collaborator
Pennine Care NHS Foundation Trust
company
Greater Manchester Mental Health NHS Foundation Trust
company
indication
Psychosis
indication
Psychosis-Related PTSD
indication
Psychotic Disorders
indication
investigator
Katherine Berry, PhD
person